- Open Access
Inflammasome and caspase-1 inhibition caused by Bcl-2 and Bcl-XL may influence cytokine responses of lipopolysaccharide-stimulated peripheral blood mononuclear cells from septic patients
Critical Care volume 16, Article number: 410 (2012)
In recent issues of Critical Care, Wu and colleagues  and Giamarellos-Bourboulis and colleagues  observed that cytokine responses in different concentrations of lipo polysaccharide (LPS) (1 and 10 pg/μL, respectively) stimulated peripheral blood mononuclear cells (PBMCs) of septic patients and healthy controls. Wu and colleagues found that interleukin-1beta (IL-1β) production of PBMCs from patients with sepsis was significantly higher than that from controls, whereas Giamarellos-Bourboulis and colleagues found the opposite result. In light of previous research, we would like to offer some remarks.
LPS can lead to the activation of nuclear factor-kappa-B (NF-κB) and the subsequent generation of pro-IL-1β , which is readily processe d into IL-1β by inflammasome-activated caspase-1 . NF-κB also induces B-cell lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-XL), both of which could suppress the activation of caspase-1 by inhibiting NLRP1 (pyrin-containing nonobese diabetic-like receptor 1) and thus suppress the cleavage of pro-IL-1β . When PBMCs were stimulated with low concentrations of LPS, the expression of pro-IL-1β could be predominant and functions of inflammasomes and caspase-1 were still reserved and thus IL-1β production was increased. When PBMCs were stimulated with high concentrations of LPS, the expression of Bcl-XL/Bcl-2 could greatly increase and lead to significant inhibition of caspase-1 and thus the production of IL-1β was decreased, although the expression of pro-IL-1β may not have been influenced significantly . That may be the reason why the results of the two sets of authors were conflicting.
Since Bcl-2/Bcl-XL could be differently produced according to various concentrations of LPS, inhibiting Bcl-2/Bcl-XL with reagents like ABT-737 in order to make sure that inflammasome and caspase-1 are not suppressed in vitro would be necessary when trying to use LPS stimulation to assess the status of PBMCs from patients with sepsis.
B-cell lymphoma 2
B-cell lymphoma-extra large
peripheral blood mononuclear cell.
Wu HP, Shih CC, Lin CY, Hua CC , Chuang DY: Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors. Crit Care 2011, 15: R224. 10.1186/cc10464
Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG: Inhibition of caspase-1 activation in gram-negative sepsis and experimental endotoxemia. Crit Care 2011, 15: R27. 10.1186/cc9974
Rittirsch D, Flierl MA, Ward PA: Harmful molecular mechanisms in sepsis. Nat Rev Immunol 2008, 8: 776-787. 10.1038/nri2402
Schroder K, Tschopp J: The inflammasomes. Cell 2010, 140: 821-832. 10.1016/j.cell.2010.01.040
Bruey JM, Bruey-Sedano N, L uciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC: Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell 2007, 129: 45-56. 10.1016/j.cell.2007.01.045
The authors declare that they have no competing interests.
About this article
Cite this article
Liu, Z., Liu, J. & Qu, H. Inflammasome and caspase-1 inhibition caused by Bcl-2 and Bcl-XL may influence cytokine responses of lipopolysaccharide-stimulated peripheral blood mononuclear cells from septic patients. Crit Care 16, 410 (2012). https://doi.org/10.1186/cc11156
- Public Health
- Mononuclear Cell
- Peripheral Blood Mononuclear Cell